MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/molecules25010020

Медицинская библиотека · Molecules (Basel, Switzerland) · 2019

In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod.

Cavalli Eugenio, Mazzon Emanuela, Basile Maria Sofia, Mammana Santa, Pennisi Manuela, Fagone Paolo, Kalfin Reni, Martinovic Vanja, Ivanovic Jovana, Andabaka Marko, Mesaros Sarlota, Pekmezovic Tatjana, Drulovic Jelena, Nicoletti Ferdinando, Petralia Maria Cristina

СтатьяПеревод в очереди

Аннотация

We evaluated the in silico expression and circulating levels of interleukin (IL)37 in patients with different forms of multiple sclerosis (MS) and also upon treatment with different disease-modifying drugs. The combined interpretation of the resulting data strengthens and extends the current emerging concept that endogenous IL37 plays an important role in determining onset and progression of MS. The in silico analysis revealed that production of IL37 from cluster of differentiation (CD)4+ T cells from MS patients was reduced in vitro as compared to healthy controls. The analysis of the datasets also demonstrated that "higher" levels of IL37 production from PBMC entailed significant protection from MS relapses. In addition, the in vivo part of the study showed that IL37 was selectively augmented in the sera of MS patients during a relapse and that treatment with the high potency disease-modifying drug fingolimod significantly increased the frequency of patients with circulating blood levels of IL37 (6/9, 66%) as compared to patients receiving no treatment (n = 48) or platform therapy (n = 59) who had levels of IL37 below the limit of the sensitivity of the assay. This finding therefore anticipates that fingolimod may at least partially exert its beneficial effects in MS by upregulating the production of IL37.

Для цитирования: Cavalli Eugenio, Mazzon Emanuela, Basile Maria Sofia, Mammana Santa, Pennisi Manuela, Fagone Paolo, Kalfin Reni, Martinovic Vanja, Ivanovic Jovana, Andabaka Marko, Mesaros Sarlota, Pekmezovic Tatjana, Drulovic Jelena, Nicoletti Ferdinando, Petralia Maria Cristina. In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod.. Molecules (Basel, Switzerland). 2019. DOI: 10.3390/molecules25010020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.